Clinical Trial Update: Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects and safety of different Bambuterol doses in Chinese patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Bambuterol (bambuterol)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: COPD | Phase 4 | Status: COMPLETED